Fresenius Will Pay $250M to Settle Dialysis Claims

Fresenius Medical Care will shell out $250 million to settle more than 400 lawsuits alleging harm from two of its drugs, GranuFlo and NaturaLyte, under a proposed settlement.

The settlement includes a caveat: the terms of the deal must be accepted by 97 percent of the plaintiffs by July, according to Fresenius.

The lawsuits accuse the company of negligence, contending that the two drugs change the pH balance in patients’ tissue, raising it to dangerously acidic levels that can trigger cardiac arrest.